Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2017 | Pages:
105 | Publisher: JP Research
Industry: ICT | Report Format: Electronic (PDF)
The global Biosimulation market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.
Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.
This report, with focus on top players in the global and Japan, studies the Biosimulation market's development status and future trend in the global and Japan. It splits Biosimulation market by type and by applications to fully and deeply research and reveal market profile and prospect.
The major players include
Certara USA, Inc. (U.S.)
Simulation Plus Inc. (U.S.)
Dassault Systemes SA (France)
Schrodinger Inc. (U.S.)
Advanced Chemistry Development, Inc. (Canada)
Chemical Computing Group, Inc. (Canada)
Physiomics PLC (U.K.)
Entelos Holding Corporation (U.S.)
Rhenovia Pharma Ltd. (France)
Genedata AG (Switzerland)
Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others
On the basis of product, the Biosimulation market is primarily split into
By Segmentation
Software
Services
By Phase
Drug Development
Drug Discovery
Others
Key Applications
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organization
Regulatory Authorities
Others
Table of Contents
2017-2022 Global and Japan Biosimulation Market Analysis Report
1 Biosimulation Overview
1.1 Product Overview and Scope of Biosimulation
1.2 Global and Japan Biosimulation Market by Applications/End Users
1.2.1 Japan Biosimulation Sales (K Units) and Market Share Comparison by Applications (2012-2017)
1.2.1.1 Japan Biosimulation Sales (K Units) and Market Share by Applications (2012-2017)
1.2.1.2 Japan Biosimulation Sales Growth Rate (%) by Applications (2012-2017)
1.2.1.3 Market Drivers and Opportunities
1.2.2 Japan Biosimulation Sales (K Units) and Market Share Comparison by Applications (2012-2017)
1.2.3 Global Biosimulation Sales by Application (2012-2017)
1.2.3.1 Global Biosimulation Sales (K Units) and Market Share by Applications (2012-2017)
1.2.3.2 Global Biosimulation Sales Growth Rate (%) by Applications (2012-2017)
1.2.3.3 Market Drivers and Opportunities
1.2.4 Global Biosimulation Sales (K Units) and Market Share Comparison by Applications (2012-2017)
1.2.5 Academic and Government Research Institutes
1.2.6 Pharmaceutical and Biotechnology Companies
1.2.7 Contract Research Organization
1.2.8 Regulatory Authorities
1.2.9 Others
1.3 Global and Japan Market Size (Sales and Revenue) of Biosimulation (2012-2017)
1.3.1 Japan Market Size (Sales and Revenue) of Biosimulation (2012-2017)
1.3.1.1 Japan Biosimulation Sales (K Units) and Growth Rate (%) (2012-2017)
1.3.1.2 Japan Biosimulation Revenue (Million USD) and Growth Rate (2012-2017)
1.3.2 Global Market Size (Sales and Revenue) of Biosimulation (2012-2017)
1.3.2.1 Global Biosimulation Sales (K Units) and Growth Rate (%) (2012-2017)
1.3.2.2 Global Biosimulation Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Biosimulation by Segmentation
1.4.1 Japan Biosimulation Sales (K Units) and Market Share by Segmentation (2012-2017)
1.4.2 Global Biosimulation Sales (K Units) and Market Share by Segmentation (2012-2017)
1.4.3 Japan Biosimulation Revenue (Million USD) and Market Share by Segmentation (2012-2017)
1.4.4 Global Biosimulation Revenue (Million USD) and Market Share by Segmentation (2012-2017)
1.4.5 Japan Biosimulation Price (USD/Unit) by Segmentation (2012-2017)
1.4.6 Global Biosimulation Price (USD/Unit) by Segmentation (2012-2017)
1.4.7 Japan Biosimulation Sales Growth Rate (%) by Segmentation (2012-2017)
1.4.8 Global Biosimulation Sales Growth Rate (%) by Segmentation (2012-2017)
1.4.9 Software
1.4.10 Services
1.5 Global and Japan Classification of Biosimulation by Phase
1.5.1 Japan Biosimulation Sales (K Units) and Market Share by Phase (2012-2017)
1.5.2 Global Biosimulation Sales (K Units) and Market Share by Phase (2012-2017)
1.5.3 Japan Biosimulation Revenue (Million USD) and Market Share by Phase (2012-2017)
1.5.4 Global Biosimulation Revenue (Million USD) and Market Share by Phase (2012-2017)
1.5.5 Japan Biosimulation Price (USD/Unit) by Phase (2012-2017)
1.5.6 Global Biosimulation Price (USD/Unit) by Phase (2012-2017)
1.5.7 Japan Biosimulation Sales Growth Rate (%) by Phase (2012-2017)
1.5.8 Global Biosimulation Sales Growth Rate (%) by Phase (2012-2017)
1.5.9 Drug Development
1.5.10 Drug Discovery
1.5.11 Others
2 Global and Japan Biosimulation Market Competition by Players/Manufacturers
2.1 Japan Biosimulation Market Competition by Players/Manufacturers
2.1.1 Japan Biosimulation Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.1.2 Japan Biosimulation Revenue and Share by Players/Manufacturers (2012-2017)
2.1.3 Japan Biosimulation Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.1.4 Japan Biosimulation Market Competitive Situation and Trends
2.1.4.1 Japan Biosimulation Market Concentration Rate
2.1.4.2 Japan Biosimulation Market Share of Top 3 and Top 5 Players/Manufacturers
2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.1.5 Japan Players/Manufacturers Biosimulation Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Biosimulation Market Competition by Players/Manufacturers
2.2.1 Global Biosimulation Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2.2 Global Biosimulation Revenue and Share by Players/Manufacturers (2012-2017)
2.2.3 Global Biosimulation Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.2.4 Global Biosimulation Market Competitive Situation and Trends
2.2.4.1 Global Biosimulation Market Concentration Rate
2.2.4.2 Global Biosimulation Market Share of Top 3 and Top 5 Players/Manufacturers
2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
2.2.5 Global Players/Manufacturers Biosimulation Manufacturing Base Distribution, Sales Area, Product Types
3 Global and Japan Biosimulation Sales and Revenue by Regions (2012-2017)
3.1 Asia Pacific Biosimulation Sales and Revenue by Regions (2012-2017)
3.1.1 Japan Biosimulation Sales and Revenue (2012-2017)
3.1.1.1 Japan Biosimulation Sales (K Units) and Market Share (2012-2017)
3.1.1.2 Japan Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.1.1.3 Japan Biosimulation Price (USD/Unit)(2012-2017)
3.1.2 China Biosimulation Sales and Revenue (2012-2017)
3.1.2.1 China Biosimulation Sales (K Units) and Market Share (2012-2017)
3.1.2.2 China Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.1.2.3 China Biosimulation Price (USD/Unit)(2012-2017)
3.1.3 Korea Biosimulation Sales and Revenue (2012-2017)
3.1.3.1 Korea Biosimulation Sales (K Units) and Market Share (2012-2017)
3.1.3.2 Korea Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.1.3.3 Korea Biosimulation Price (USD/Unit)(2012-2017)
3.1.4 India Biosimulation Sales and Revenue (2012-2017)
3.1.4.1 India Biosimulation Sales (K Units) and Market Share (2012-2017)
3.1.4.2 India Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.1.4.3 India Biosimulation Price (USD/Unit)(2012-2017)
3.1.5 Others Biosimulation Sales and Revenue (2012-2017)
3.1.5.1 Others Biosimulation Sales (K Units) and Market Share (2012-2017)
3.1.5.2 Others Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.1.5.3 Others Biosimulation Price (USD/Unit)(2012-2017)
3.2 Europe Biosimulation Sales and Revenue by Regions (2012-2017)
3.2.1 France Biosimulation Sales and Revenue (2012-2017)
3.2.1.1 France Biosimulation Sales (K Units) and Market Share (2012-2017)
3.2.1.2 France Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.2.1.3 France Biosimulation Price (USD/Unit)(2012-2017)
3.2.2 Germany Biosimulation Sales and Revenue (2012-2017)
3.2.2.1 Germany Biosimulation Sales (K Units) and Market Share (2012-2017)
3.2.2.2 Germany Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.2.2.3 Germany Biosimulation Price (USD/Unit)(2012-2017)
3.2.3 United Kingdom Biosimulation Sales and Revenue (2012-2017)
3.2.3.1 United Kingdom Biosimulation Sales (K Units) and Market Share (2012-2017)
3.2.3.2 United Kingdom Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.2.3.3 United Kingdom Biosimulation Price (USD/Unit)(2012-2017)
3.2.4 Italy Biosimulation Sales and Revenue (2012-2017)
3.2.4.1 Italy Biosimulation Sales (K Units) and Market Share (2012-2017)
3.2.4.2 Italy Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.2.4.3 Italy Biosimulation Price (USD/Unit)(2012-2017)
3.2.5 Russia Biosimulation Sales and Revenue (2012-2017)
3.2.5.1 Russia Biosimulation Sales (K Units) and Market Share (2012-2017)
3.2.5.2 Russia Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.2.5.3 Russia Biosimulation Price (USD/Unit)(2012-2017)
3.2.6 Others Biosimulation Sales and Revenue (2012-2017)
3.2.6.1 Others Biosimulation Sales (K Units) and Market Share (2012-2017)
3.2.6.2 Others Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.2.6.3 Others Biosimulation Price (USD/Unit)(2012-2017)
3.3 North America Biosimulation Sales and Revenue by Regions (2012-2017)
3.3.1 United States Biosimulation Sales and Revenue (2012-2017)
3.3.1.1 United States Biosimulation Sales (K Units) and Market Share (2012-2017)
3.3.1.2 United States Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.3.1.3 United States Biosimulation Price (USD/Unit)(2012-2017)
3.3.2 Canada Biosimulation Sales and Revenue (2012-2017)
3.3.2.1 Canada Biosimulation Sales (K Units) and Market Share (2012-2017)
3.3.2.2 Canada Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.3.2.3 Canada Biosimulation Price (USD/Unit)(2012-2017)
3.4 Latin America Biosimulation Sales and Revenue by Regions (2012-2017)
3.4.1 Brazil Biosimulation Sales and Revenue (2012-2017)
3.4.1.1 Brazil Biosimulation Sales (K Units) and Market Share (2012-2017)
3.4.1.2 Brazil Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.4.1.3 Brazil Biosimulation Price (USD/Unit)(2012-2017)
3.4.2 Mexico Biosimulation Sales and Revenue (2012-2017)
3.4.2.1 Mexico Biosimulation Sales (K Units) and Market Share (2012-2017)
3.4.2.2 Mexico Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.4.2.3 Mexico Biosimulation Price (USD/Unit)(2012-2017)
3.4.3 Others Biosimulation Sales and Revenue (2012-2017)
3.4.3.1 Others Biosimulation Sales (K Units) and Market Share (2012-2017)
3.4.3.2 Others Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.4.3.3 Others Biosimulation Price (USD/Unit)(2012-2017)
3.5 Southeast Asia Biosimulation Sales and Revenue by Regions (2012-2017)
3.5.1 Singapore Biosimulation Sales and Revenue (2012-2017)
3.5.1.1 Singapore Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.1.2 Singapore Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.1.3 Singapore Biosimulation Price (USD/Unit)(2012-2017)
3.5.2 Malaysia Biosimulation Sales and Revenue (2012-2017)
3.5.2.1 Malaysia Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.2.2 Malaysia Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.2.3 Malaysia Biosimulation Price (USD/Unit)(2012-2017)
3.5.3 Vietnam Biosimulation Sales and Revenue (2012-2017)
3.5.3.1 Vietnam Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.3.2 Vietnam Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.3.3 Vietnam Biosimulation Price (USD/Unit)(2012-2017)
3.5.4 Myanmar Biosimulation Sales and Revenue (2012-2017)
3.5.4.1 Myanmar Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.4.2 Myanmar Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.4.3 Myanmar Biosimulation Price (USD/Unit)(2012-2017)
3.5.5 Thailand Biosimulation Sales and Revenue (2012-2017)
3.5.5.1 Thailand Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.5.2 Thailand Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.5.3 Thailand Biosimulation Price (USD/Unit)(2012-2017)
3.5.6 Indonesia Biosimulation Sales and Revenue (2012-2017)
3.5.6.1 Indonesia Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.6.2 Indonesia Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.6.3 Indonesia Biosimulation Price (USD/Unit)(2012-2017)
3.5.7 Philippines Biosimulation Sales and Revenue (2012-2017)
3.5.7.1 Philippines Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.7.2 Philippines Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.7.3 Philippines Biosimulation Price (USD/Unit)(2012-2017)
3.5.8 Others Biosimulation Sales and Revenue (2012-2017)
3.5.8.1 Others Biosimulation Sales (K Units) and Market Share (2012-2017)
3.5.8.2 Others Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.5.8.3 Others Biosimulation Price (USD/Unit)(2012-2017)
3.6 Middle East & Africa Biosimulation Sales and Revenue by Regions (2012-2017)
3.6.1 Saudi Arabia Biosimulation Sales and Revenue (2012-2017)
3.6.1.1 Saudi Arabia Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.1.2 Saudi Arabia Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.1.3 Saudi Arabia Biosimulation Price (USD/Unit)(2012-2017)
3.6.2 Iran Biosimulation Sales and Revenue (2012-2017)
3.6.2.1 Iran Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.2.2 Iran Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.2.3 Iran Biosimulation Price (USD/Unit)(2012-2017)
3.6.3 UAE Biosimulation Sales and Revenue (2012-2017)
3.6.3.1 UAE Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.3.2 UAE Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.3.3 UAE Biosimulation Price (USD/Unit)(2012-2017)
3.6.4 Turkey Biosimulation Sales and Revenue (2012-2017)
3.6.4.1 Turkey Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.4.2 Turkey Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.4.3 Turkey Biosimulation Price (USD/Unit)(2012-2017)
3.6.5 Israel Biosimulation Sales and Revenue (2012-2017)
3.6.5.1 Israel Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.5.2 Israel Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.5.3 Israel Biosimulation Price (USD/Unit)(2012-2017)
3.6.6 Egypt Biosimulation Sales and Revenue (2012-2017)
3.6.6.1 Egypt Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.6.2 Egypt Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.6.3 Egypt Biosimulation Price (USD/Unit)(2012-2017)
3.6.7 South Africa Biosimulation Sales and Revenue (2012-2017)
3.6.7.1 South Africa Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.7.2 South Africa Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.7.3 South Africa Biosimulation Price (USD/Unit)(2012-2017)
3.6.8 Others Biosimulation Sales and Revenue (2012-2017)
3.6.8.1 Others Biosimulation Sales (K Units) and Market Share (2012-2017)
3.6.8.2 Others Biosimulation Revenue (Million USD) and Market Share (2012-2017)
3.6.8.3 Others Biosimulation Price (USD/Unit)(2012-2017)
4 Global and Japan Biosimulation Players/Manufacturers Profiles and Sales Data
4.1 Certara USA, Inc. (U.S.)
4.1.1 Company Basic Information, Manufacturing Base and Competitors
4.1.2 Biosimulation Product Category, Application and Specification
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 Certara USA, Inc. (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.1.4 Main Business/Business Overview
4.2 Simulation Plus Inc. (U.S.)
4.2.1 Company Basic Information, Manufacturing Base and Competitors
4.2.2 Biosimulation Product Category, Application and Specification
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 Simulation Plus Inc. (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.2.4 Main Business/Business Overview
4.3 Dassault Systemes SA (France)
4.3.1 Company Basic Information, Manufacturing Base and Competitors
4.3.2 Biosimulation Product Category, Application and Specification
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 Dassault Systemes SA (France) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.3.4 Main Business/Business Overview
4.4 Schrodinger Inc. (U.S.)
4.4.1 Company Basic Information, Manufacturing Base and Competitors
4.4.2 Biosimulation Product Category, Application and Specification
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Schrodinger Inc. (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.4.4 Main Business/Business Overview
4.5 Advanced Chemistry Development, Inc. (Canada)
4.5.1 Company Basic Information, Manufacturing Base and Competitors
4.5.2 Biosimulation Product Category, Application and Specification
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.5.4 Main Business/Business Overview
4.6 Chemical Computing Group, Inc. (Canada)
4.6.1 Company Basic Information, Manufacturing Base and Competitors
4.6.2 Biosimulation Product Category, Application and Specification
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 Chemical Computing Group, Inc. (Canada) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.6.4 Main Business/Business Overview
4.7 Physiomics PLC (U.K.)
4.7.1 Company Basic Information, Manufacturing Base and Competitors
4.7.2 Biosimulation Product Category, Application and Specification
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Physiomics PLC (U.K.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.7.4 Main Business/Business Overview
4.8 Entelos Holding Corporation (U.S.)
4.8.1 Company Basic Information, Manufacturing Base and Competitors
4.8.2 Biosimulation Product Category, Application and Specification
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 Entelos Holding Corporation (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.8.4 Main Business/Business Overview
4.9 Rhenovia Pharma Ltd. (France)
4.9.1 Company Basic Information, Manufacturing Base and Competitors
4.9.2 Biosimulation Product Category, Application and Specification
4.9.2.1 Product A
4.9.2.2 Product B
4.9.3 Rhenovia Pharma Ltd. (France) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.9.4 Main Business/Business Overview
4.10 Genedata AG (Switzerland)
4.10.1 Company Basic Information, Manufacturing Base and Competitors
4.10.2 Biosimulation Product Category, Application and Specification
4.10.2.1 Product A
4.10.2.2 Product B
4.10.3 Genedata AG (Switzerland) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.10.4 Main Business/Business Overview
5 Biosimulation Manufacturing Cost Analysis
5.1 Biosimulation Key Raw Materials Analysis
5.1.1 Key Raw Materials
5.1.2 Price Trend of Key Raw Materials
5.1.3 Key Suppliers of Raw Materials
5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
5.2.1 Raw Materials
5.2.2 Labor Cost
5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Biosimulation
6 Industrial Chain, Sourcing Strategy and Downstream Buyers
6.1 Biosimulation Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Biosimulation Major Players/Manufacturers in 2016
6.4 Downstream Buyers
7 Marketing Strategy Analysis, Distributors/Traders
7.1 Marketing Channel
7.1.1 Direct Marketing
7.1.2 Indirect Marketing
7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
7.2.1 Pricing Strategy
7.2.2 Brand Strategy
7.2.3 Target Client
7.3 Distributors/Traders List
8 Market Effect Factors Analysis
8.1 Technology Progress/Risk
8.1.1 Substitutes Threat
8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change
9 Global and Japan Biosimulation Market Size (Sales and Revenue) Forecast (2017-2022)
9.1 Global and Japan Biosimulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Biosimulation Sales (K Units) Forecast by Type (2017-2022)
9.2.1 by Segmentation
9.2.2 by Phase
9.3 Global and Japan Biosimulation Sales (K Units) Forecast by Application (2017-2022)
9.4 Global and Japan Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List
List of Tables and Figures
Figure Product Picture of Biosimulation
Table Japan Biosimulation Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Biosimulation by Applications in 2016
Table Global Biosimulation Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Biosimulation by Applications in 2016
Figure Academic and Government Research Institutes Examples
Table Key Downstream Customer in Academic and Government Research Institutes
Figure Pharmaceutical and Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical and Biotechnology Companies
Figure Contract Research Organization Examples
Table Key Downstream Customer in Contract Research Organization
Figure Regulatory Authorities Examples
Table Key Downstream Customer in Regulatory Authorities
Figure Others Examples
Table Key Downstream Customer in Others
Figure Software Product Picture
Figure Services Product Picture
Figure Drug Development Product Picture
Figure Drug Discovery Product Picture
Figure Others Product Picture
Table Certara USA, Inc. (U.S.) Basic Information List
Table Certara USA, Inc. (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Certara USA, Inc. (U.S.) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Certara USA, Inc. (U.S.) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Certara USA, Inc. (U.S.) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Simulation Plus Inc. (U.S.) Basic Information List
Table Simulation Plus Inc. (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Simulation Plus Inc. (U.S.) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Simulation Plus Inc. (U.S.) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Simulation Plus Inc. (U.S.) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Dassault Systemes SA (France) Basic Information List
Table Dassault Systemes SA (France) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Dassault Systemes SA (France) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Dassault Systemes SA (France) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Dassault Systemes SA (France) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Schrodinger Inc. (U.S.) Basic Information List
Table Schrodinger Inc. (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Schrodinger Inc. (U.S.) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Schrodinger Inc. (U.S.) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Schrodinger Inc. (U.S.) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Advanced Chemistry Development, Inc. (Canada) Basic Information List
Table Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Advanced Chemistry Development, Inc. (Canada) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Chemical Computing Group, Inc. (Canada) Basic Information List
Table Chemical Computing Group, Inc. (Canada) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Chemical Computing Group, Inc. (Canada) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Chemical Computing Group, Inc. (Canada) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Chemical Computing Group, Inc. (Canada) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Physiomics PLC (U.K.) Basic Information List
Table Physiomics PLC (U.K.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Physiomics PLC (U.K.) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Physiomics PLC (U.K.) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Physiomics PLC (U.K.) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Entelos Holding Corporation (U.S.) Basic Information List
Table Entelos Holding Corporation (U.S.) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Entelos Holding Corporation (U.S.) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Entelos Holding Corporation (U.S.) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Entelos Holding Corporation (U.S.) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Rhenovia Pharma Ltd. (France) Basic Information List
Table Rhenovia Pharma Ltd. (France) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Rhenovia Pharma Ltd. (France) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Rhenovia Pharma Ltd. (France) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Rhenovia Pharma Ltd. (France) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Genedata AG (Switzerland) Basic Information List
Table Genedata AG (Switzerland) Biosimulation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Genedata AG (Switzerland) Biosimulation Sales Growth Rate (%)(2012-2017)
Table Genedata AG (Switzerland) Biosimulation Sales Market Share (%) in Japan (2012-2017)
Figure Genedata AG (Switzerland) Biosimulation Revenue Market Share (%) in Japan (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimulation
Figure Manufacturing Process Analysis of Biosimulation
Figure Biosimulation Industrial Chain Analysis
Table Raw Materials Sources of Biosimulation Major Players/Manufacturers in 2016
Table Major Buyers of Biosimulation
Table Distributors/Traders List
Figure Japan Biosimulation Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Biosimulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimulation Price (USD/Unit) Trend Forecast (2017-2022)
Figure Global Biosimulation Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Biosimulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biosimulation Price (USD/Unit) Trend Forecast (2017-2022)
Table Japan Biosimulation Sales (K Units) Forecast by Type (2017-2022)
Table Global Biosimulation Sales (K Units) Forecast by Type (2017-2022)
Figure Japan Biosimulation Sales (K Units) Forecast by Type (2017-2022)
Figure Global Biosimulation Sales (K Units) Forecast by Type (2017-2022)
Figure Japan Biosimulation Sales Volume Market Share Forecast by Type in 2017
Figure Global Biosimulation Sales Volume Market Share Forecast by Type in 2017
Table Japan Biosimulation Sales (K Units) Forecast by Application (2017-2022)
Figure Japan Biosimulation Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Biosimulation Sales Volume Market Share Forecast by Application in 2017
Table Global Biosimulation Sales (K Units) Forecast by Application (2017-2022)
Figure Global Biosimulation Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Biosimulation Sales Volume Market Share Forecast by Application in 2017
Table Japan Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
Table Japan Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
Table Global Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
Table Global Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
